Article Details

Sierra Oncology (NASDAQ:SRRA) Downgraded by Zacks Investment Research

Retrieved on: 2019-10-14 08:22:30

Tags for this article:

Click the tags to see associated articles and topics

Sierra Oncology (NASDAQ:SRRA) Downgraded by Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC now owns 2,312,634 shares of the biotechnology company's stock valued at $1,295,000 after purchasing an ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up